A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

DELAWARE, DE, UNITED STATES, July 4, 2025 /EINPresswire.com/ -- The global Attention Deficit Hyperactivity Disorder (ADHD) market is anticipated to reach USD 18.3 billion by 2025, as a result of ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

People with ADHD often struggle with executive function, which Didier describes as “your brain’s GPS” for navigating your day ...

Attention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...

When combined, a subjective list of common childhood behaviors (fidgeting, losing things, distractibility, not following ...

Discover a study that explores how a personalised mHealth exercise program can effectively improve ADHD symptoms in children.

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the risk of weight loss ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...